Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$9.56
-3.9%
$10.94
$4.88
$14.88
$1.38B1.391.98 million shs2.30 million shs
AtriCure, Inc. stock logo
ATRC
AtriCure
$32.69
-3.7%
$37.98
$18.94
$43.11
$1.60B1.53666,336 shs792,283 shs
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$20.00
$19.98
$12.26
$20.57
$843.96M0.74765,906 shs4,300 shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$22.24
-7.1%
$23.81
$16.81
$36.49
$1.72B1.231.01 million shs909,670 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
+2.90%-15.17%-12.41%+2.68%-24.39%
AtriCure, Inc. stock logo
ATRC
AtriCure
+1.19%-11.06%-17.22%+1.89%-8.07%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00%0.00%0.00%0.00%0.00%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
+5.93%+9.31%-5.04%-0.83%-33.88%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
4.2316 of 5 stars
3.42.00.03.32.64.20.6
AtriCure, Inc. stock logo
ATRC
AtriCure
3.77 of 5 stars
4.53.00.00.03.32.50.6
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.616 of 5 stars
0.91.00.04.02.81.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
2.89
Moderate Buy$17.6784.80% Upside
AtriCure, Inc. stock logo
ATRC
AtriCure
3.00
Buy$51.5657.71% Upside
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00
N/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
1.75
Reduce$23.003.42% Upside

Current Analyst Ratings Breakdown

Latest CSII, IART, ATRC, and ATEC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/27/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$12.00 ➝ $13.00
2/27/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
2/13/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$36.00 ➝ $45.00
2/13/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$40.00 ➝ $50.00
2/13/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$36.00 ➝ $48.00
2/13/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$61.00 ➝ $66.00
2/13/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$51.00 ➝ $51.00
2/11/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$40.00 ➝ $51.00
2/10/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$60.00 ➝ $60.00
1/22/2025
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00
1/22/2025
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$40.00 ➝ $51.00
(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$611.56M2.25N/AN/A$0.57 per share16.77
AtriCure, Inc. stock logo
ATRC
AtriCure
$465.31M3.43N/AN/A$9.46 per share3.46
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$239.84M3.52N/AN/A$6.12 per share3.27
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.61B1.07$4.88 per share4.56$20.31 per share1.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$186.64M-$1.14N/AN/AN/A-31.06%-541.39%-22.99%5/6/2025 (Estimated)
AtriCure, Inc. stock logo
ATRC
AtriCure
-$44.70M-$0.95N/AN/AN/A-9.61%-6.80%-5.19%5/7/2025 (Estimated)
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M-$0.09N/A8.900.73-0.42%12.35%4.82%5/5/2025 (Estimated)

Latest CSII, IART, ATRC, and ATEC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/26/2025Q4 2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.19-$0.23-$0.04-$0.23$172.74 million$176.79 million
2/25/2025Q4 2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.85$0.97+$0.12$0.25$445.15 million$442.65 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
30.21
2.32
1.15
AtriCure, Inc. stock logo
ATRC
AtriCure
0.13
3.65
2.62
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.08
6.04
4.92
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.79
1.20
0.73

Institutional Ownership

CompanyInstitutional Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
86.61%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%

Insider Ownership

CompanyInsider Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
22.80%
AtriCure, Inc. stock logo
ATRC
AtriCure
3.20%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
3.80%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
700144.15 million109.48 millionOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,30048.88 million47.32 millionOptionable
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
78042.20 million40.59 millionOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94677.22 million74.77 millionOptionable

Recent News About These Companies

Truist Financial Remains a Hold on Integra Lifesciences (IART)
BTIG Remains a Hold on Integra Lifesciences (IART)
Integra LifeSciences sees 2025 adjusted EPS $2.41-$2.51, consensus $2.51

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alphatec stock logo

Alphatec NASDAQ:ATEC

$9.56 -0.39 (-3.92%)
Closing price 04:00 PM Eastern
Extended Trading
$9.60 +0.04 (+0.47%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

AtriCure stock logo

AtriCure NASDAQ:ATRC

$32.69 -1.25 (-3.68%)
Closing price 04:00 PM Eastern
Extended Trading
$32.70 +0.01 (+0.03%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Cardiovascular Systems stock logo

Cardiovascular Systems NASDAQ:CSII

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$22.24 -1.71 (-7.14%)
Closing price 04:00 PM Eastern
Extended Trading
$22.23 -0.01 (-0.03%)
As of 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.